Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-08

FDA Approved: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved Aurohealth LLC's cetirizine hydrochloride and pseudoephedrine hydrochloride as an original ANDA, enabling a generic combination product for relief …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride (cetirizine hydrochloride and pseudoephedrine hydrochloride)

Snippet

ORIG AP for CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)